Abstract PS1-05-12: Primary G-CSF Prophylaxis in Sacituzumab Govitecan-Treated mTNBC: Real-World Evidence from a Multinational Cohort
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Z. Bielčiková, M. Pieniążek, A. Polakiewicz-Gilowska, J. Żubrowska, M. Holánek, R. Soumarová, H. Študentová, A. Konieczna, M. Malejčíková, A. Młodzińska, K. Winsko-Szczęsnowicz, M. Lisik-Habib, A. Pękala, D. Krejčí, J. Šustr, I. Kolářová, I. Danielewicz, M. Szymanik-Resko, T. Ciszewski, L. Rusinova, B. Czartoryska-Arłukowicz, A. Łacko, R. Pacholczak-Madej, M. Jarzab, M. Püsküllüoğlu, M. Kubeczko
Institutions: Charles University, General University Hospital in Prague, Wroclaw Medical University, The Maria Sklodowska-Curie National Research Institute of Oncology, Masaryk University, Masaryk Memorial Cancer Institute, University Hospital Kralovske Vinohrady, University Hospital Olomouc, Palacký University Olomouc, Fakultní nemocnice Bulovka, University Hospital Plzen, University Hospital Hradec Králové, Medical University of Lublin, Štefan Kukura Hospital in Michalovce
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7130728123
Cites:
Cited by:
Related to:
